1993
DOI: 10.1111/j.1651-2227.1993.tb12817.x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of severe pertussis by administration of specific gamma globulin with high titers anti‐toxin antibody

Abstract: Our patient presented with severe respiratory distress and marked pleocytosis. She was mechanically ventilated and received gamma globulin with high titers of anti-pertussis toxin and anti-filamentous hemagglutinin. Her clinical signs improved and a notable decrease in white blood cell count was observed. Ten months after treatment, the patient showed normal physical and mental development and anti-pertussis toxin and anti-filamentous hemagglutinin titers were significantly increased. Recently, the effectivene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

1995
1995
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 8 publications
0
3
0
1
Order By: Relevance
“…Human hyperimmune pertussis globulin is still used occasionally [90,91]. Further treatment is symptomatic.…”
Section: Treatment and Preventionmentioning
confidence: 99%
“…Human hyperimmune pertussis globulin is still used occasionally [90,91]. Further treatment is symptomatic.…”
Section: Treatment and Preventionmentioning
confidence: 99%
“…However, because of small sample sizes, different drugs and varying dosage regimens, confirmatory studies are required to determine the efficacy of steroids in the management of pertussis. Other investigational therapies, such as intravenous pertussis immune globulin (19)(20)(21), require further demonstration of effectiveness before they can be widely recommended.…”
Section: Discussionmentioning
confidence: 99%
“…Estudios posteriores indicaron que la gammaglubilina utilizada presentaba baja concentración de anticuerpos específicos antitoxina. En un estudio murino usando gammaglobulina hiperinmune se logró mayor sobrevida y disminución de los síntomas, además de reducción en el recuento leucocitario, por lo tanto se debe usar esta inmunoglobulina y no la standard (17)(18)(19)(20)(21)(22)(23)(24)(25) .…”
Section: Conclusionesunclassified